James Frederick, PA-C, MMSc, —

James Frederick is a practicing Physician Associate (PA-C, MMSc) who studied at Yale University. He also has a bachelor’s degree in creative writing and English Literature from the University of Colorado. He specializes in writing medical content that is approachable, readable and enjoyable. He has a strong background in research, physiology, pharmacotherapy, emergency medicine and critical care medicine. In his free time, he enjoys spending time camping and traveling with his wife and dog.

Articles by James Frederick

April 4, 2017 News by James Frederick, PA-C, MMSc

Positive Phase 1 Parkinson’s Trial Results of New Therapy Reported by Prothena

Prothena recently presented results from a Phase 1b clinical trial investigating a new antibody therapy for the treatment of Parkinson’s disease at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) in Vienna, Austria. The trial was an ascending dose study of a novel antibody known as PRX002/RG7935.

March 14, 2017 News by James Frederick, PA-C, MMSc

3-D Images of Mutated Protein Variations May Increase Understanding of Parkinson’s

3-D images of 11 mutant versions of a protein connected with Parkinson’s disease (PD) and amyotrophic lateral sclerosis (ALS) are helping scientists understand how the mutations changed the structure of the protein and damaged its functioning. The study, “Structural insights into human angiogenin (ANG) variants implicated in Parkinson’s disease…

Subscribe to our newsletter

Get regular updates to your inbox.

James Frederick, PA-C, MMSc, —

Articles by James Frederick

Positive Phase 1 Parkinson’s Trial Results of New Therapy Reported by Prothena

3-D Images of Mutated Protein Variations May Increase Understanding of Parkinson’s

Recent Posts

Your Parkinson’s Community

Subscribe to our newsletter